Serial #79368245
LIVE

Serial Number

79368245

Owner

Dr. Schär AG/SPA

Attorney

Molly Buck Richard

Filing Date

Dec 1, 2022

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79368245 Trademark

Serial Number: 79368245 • Registration: 7459200

Serial #79368245 is a trademark filed by Dr. Schär AG/SPA on December 1, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 41 (Education & Entertainment), Class 43 (Hotels & Restaurants), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Dr. Schär AG/SPA (25 trademarks)

Winkelau 9

Entity Type: 99

Trademark Details

Filing Date

December 1, 2022

Registration Date

July 30, 2024

Published for Opposition

January 9, 2024

Goods & Services

Consultancy in the fields of restaurants, hotel accommodation; providing of information on the internet and other media relating to restaurants, hotel accommodation

Providing medical information relating to coeliac disease, allergies, intolerances and gluten-free nutrition; providing medical information to patients and medical professionals in the form of medical reports, information and answer catalogues relating to coeliac disease, allergies, intolerances and gluten-free nutrition; medical consultancy in the fields of coeliac disease, allergies, intolerances and gluten-free nutrition

Arranging and conducting of events, namely, conferences, congresses, seminars, symposiums, workshops, webinars and training courses, via the internet and on demand in the fields of coeliac disease, allergies, intolerances and gluten-free nutrition; publishing services, namely, publication of guidelines and recipes in the field of diets, healthy lifestyles and disease prevention; providing online electronic publications in the nature of guidelines and recipes in the field of diets, healthy lifestyles and disease prevention; electronic desktop publishing; publication of medical publications relating to coeliac disease, allergies, intolerances and gluten-free nutrition; library services provided by means of a computerised database; providing of training and further training, namely, in the form of e-learning via the internet and correspondence courses in the fields of coeliac disease, allergies, intolerances and gluten-free nutrition

Telecommunication access services by means of platforms and portals on the internet; providing access to databases; providing internet chatrooms; providing multiple-user access to a global computer information network; providing multiple-user access to electronic communications networks and electronic databases; mobile telephone communication; electronic transmission of computer software via the internet and other communications networks; electronic transmission of text, data, image, audio, video and multimedia content via the internet or other communications networks; providing chat lines utilising the internet; communications services, namely, electronic exchange of data stored in databases accessible via telecommunication networks

Downloadable mobile phone applications for remote assistance in the medical field; downloadable mobile phone applications for setting up appointments with health care practitioners; downloadable computer software for accessing, downloading and digitally viewing information on mobile telephones; sound, audio, visual and audio-visual recordings featuring medical information provided by downloading and streaming from computers and communications networks, namely, the internet and the world wide web

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Dec 25, 2025 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 12, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 12, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 12, 2025 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 15, 2025 FINO
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jan 29, 2025 LIMN
FINAL DISPOSITION NOTICE SENT TO IB
Jan 28, 2025 FICS
FINAL DISPOSITION PROCESSED
Jan 28, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 30, 2024 FICR
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Oct 23, 2024 LIMN
LIMITATION OF GOODS RECEIVED FROM IB
Aug 17, 2024 LIMG
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 30, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 30, 2024 R.PR
LIMITATION OF GOODS RECEIVED FROM IB
Jul 7, 2024 LIMG
TTAB RELEASE CASE TO TRADEMARKS
Jun 24, 2024 TMBN
OPPOSITION TERMINATED NO. 999999
Jun 24, 2024 OP.T
OPPOSITION DISMISSED NO. 999999
Jun 24, 2024 OP.D
REFUSAL PROCESSED BY IB
Mar 4, 2024 RFNP
OPPOSITION INSTITUTED NO. 999999
Feb 12, 2024 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Feb 8, 2024 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Feb 8, 2024 OPNC
OPPOSITION PAPERS RECEIVED AT TTAB
Feb 7, 2024 OPPF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 9, 2024 PUBO
NOTIFICATION PROCESSED BY IB
Jan 8, 2024 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 20, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 20, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 20, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 30, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 29, 2023 XAEC
ASSIGNED TO LIE
Nov 28, 2023 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 27, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 27, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 27, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 21, 2023 TROA
REFUSAL PROCESSED BY IB
Jul 22, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 22, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jun 22, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 18, 2023 RFCR
NON-FINAL ACTION WRITTEN
May 17, 2023 CNRT
ASSIGNED TO EXAMINER
May 10, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
May 2, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 28, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 27, 2023 REPR